Detection of multidrug-resistant organisms of concern including Stenotrophomonas maltophilia and Burkholderia cepacia at a referral hospital in Kenya

PLoS One. 2024 Apr 16;19(4):e0298873. doi: 10.1371/journal.pone.0298873. eCollection 2024.

Abstract

Regular monitoring of bacterial susceptibility to antibiotics in clinical settings is key for ascertaining the current trends as well as re-establish empirical therapy. This study aimed to determine bacterial contaminants and their antimicrobial susceptibility patterns from medical equipment, inanimate surfaces and clinical samples obtained from Thika Level V Hospital (TLVH), Thika, in Central Kenya. Three hundred and five samples were collected between the period of March 2021 to November 2021 and comprised urine, pus swabs, catheter swabs, stool, and environmental samples. Bacterial identification and antimicrobial susceptibility were performed using VITEK 2 and disc diffusion respectively. We observed that Coagulase-negative Staphylococci (28 /160, 17.5%) were the most commonly isolated species from clinical samples followed by E. coli (22 /160 13.8%) and S. aureus (22/160, 13.8%). The bed rails were the mostly contaminated surface with S. aureus accounting for 14.2% (6/42). Among the clinical samples, pus swabs yielded the highest number of pathogens was pus (92/160). Trauma patients had the highest proportion of isolates (67/160, 41.8%). High level of antimicrobial resistance to key antimicrobials, particularly among Enterobacterales was observed. Extended Spectrum Beta Lactamase (ESBL) phenotype was noted in 65.9% (29/44) of enteric isolates. While further ESBL genetic confirmatory studies are needed, this study highlights the urgent need for actions that mitigate the spread of antibiotic-resistant bacteria.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria
  • Burkholderia cepacia*
  • Drug Resistance, Multiple, Bacterial
  • Escherichia coli
  • Hospitals
  • Humans
  • Kenya
  • Microbial Sensitivity Tests
  • Referral and Consultation
  • Staphylococcus aureus
  • Stenotrophomonas maltophilia*
  • Suppuration
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • beta-Lactamases

Grants and funding

Funding for this work was available from The Kenya National Research Fund, grant number NRF/MKU/2017/007 awarded to Dr Jesse Gitaka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.